11 Dehydroprostaglandin F2 alpha,
11 Dehydroprostaglandin F2alpha,
11-Dehydroprostaglandin F2 alpha,
11-Dehydroprostaglandin F2alpha,
alpha, 11-Dehydroprostaglandin F2,
D2, Prostaglandin,
F2 alpha, 11-Dehydroprostaglandin,
F2alpha, 11-Dehydroprostaglandin,
PGD2,
Prostaglandin D2,
prostaglandin D2,
PGD2,
11-Dehydroprostaglandin F2-alpha,
41598-07-6,
BRN 2170623,
UNII-RXY07S6CZ2,
11-Dehydroprostaglandin F2alpha,
RXY07S6CZ2,
CHEBI:15555,
(5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate,
(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate,
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid,
[3H]PGD2,
PG2,
(5E,13E)-9,15-DIHYDROXY-11-OXOPROSTA-5,13-DIEN-1-OIC ACID,
Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9-alpha,13E,15S)-,
(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid,
[3H]prostaglandin D2,
(5z,13e)-(15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate,
[3H]-PGD2,
11-Dehydroprostaglandin F2 alpha,
prosta-glandin d2,
[3H]11-dehydroprostaglandin F2-alpha,
AC1L9LZD,
BSPBio_001486,
BML1-F05,
GTPL1881,
GTPL1891,
SCHEMBL2508829,
CHEMBL1235252,
BDBM21544,
BHMBVRSPMRCCGG-OUTUXVNYSA-N,
HMS1361K08,
HMS1791K08,
HMS1989K08,
HMS3402K08,
HMS3648M03,
2004AH,
LMFA03010004,
MFCD00077857,
ZINC85994848,
AKOS032954030,
Prostaglandin D2, >=95%, synthetic,
Prostaglandin D2, cell culture tested,
DB02056,
IDI1_033956,
NCGC00161284-01,
NCGC00161284-02,
NCGC00161284-03,
LS-125822,
5179-EP2272832A1,
5179-EP2280006A1,
5179-EP2281563A1,
5179-EP2281813A1,
5179-EP2281815A1,
5179-EP2295409A1,
5179-EP2301937A1,
5179-EP2305640A2,
5179-EP2316459A1,
5179-EP2316824A1,
C00696,
198163-EP2270004A1,
198163-EP2272825A2,
198163-EP2272827A1,
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoate,
SR-01000946237,
SR-01000946237-1,
E8965369-341A-46F4-8677-2CEB4F9432BA,
(5Z,13E)-(15S)-9,15-dihydroxy-11-oxoprosta-5,13-dienoate,
(5Z,13E)-(15S)-9,15-dihydroxy-11-oxoprosta-5,13-dienoic acid,
(5Z,13E)-(15S)-9a,15-Dihydroxy-11-oxoprosta-5,13-dienoate,
(5Z,13E)-(15S)-9a,15-Dihydroxy-11-oxoprosta-5,13-dienoic acid,
(5Z,13E,15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate,
(5Z,13E,15S)-9a,15-dihydroxy-11-oxoprosta-5,13-dien-1-oate,
(5z,13e)-(15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic acid,
(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoic acid,
(5Z,13E,15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoic acid,
(5Z,13E,15S)-9a,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid,
(5Z,13E,15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid,
(5Z,9-alpha,13E,15S)-9,15-dihydroxy-11-oxo-Prosta-5,13-dien-1-oate,
(5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oate,
(5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxo-prosta-5,13-dien-1-oic acid,
(5Z,9alpha,13E,15S)-9,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid,
(5Z,9alpha,13E,15S)-9,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic-acid,
(5Z,9-alpha,13E,15S)-9,15-dihydroxy-11-oxo-Prosta-5,13-dien-1-oic acid,
(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid,
D2, Prostaglandin,
D06KBO,
D0H8QQ,
11 Dehydroprostaglandin F2alpha,
FA(20:2(OH2,Ke,cyclo)),
11 Dehydroprostaglandin F2 alpha,
F2alpha, 11-Dehydroprostaglandin,
alpha, 11-Dehydroprostaglandin F2,
F2 alpha, 11-Dehydroprostaglandin,
C20H32O5,
CID448457,
C20-H32-O5,
D015230,
Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9alpha,13E,15S)-,